%0 Journal Article
%T Cilnidipine, a Dual L/N-type Ca2+ Channel Blocker in Hypertension Management: A Review.
%A Mehta KK
%A Tiwaskar M
%A Kasture P
%J J Assoc Physicians India
%V 72
%N 4
%D 2024 Apr
%M 38881084
暂无%R 10.59556/japi.72.0516
%X Calcium channel blockers (CCBs) are widely used antihypertensive agents due to their effectiveness in reducing blood pressure (BP), along with their good tolerability and evidence of reducing hypertension (HTN)-related cardiovascular and renal diseases. Cilnidipine, a unique dihydropyridine calcium antagonist, exhibits potent inhibitory action on both N-type and L-type voltage-dependent calcium channels. With excellent oral absorption and a prolonged duration of action, it demonstrates a significant antihypertensive effect. It effectively reduces BP both systolic and diastolic while providing renal, neurological, and cardiovascular protection. Unlike L-type CCBs, cilnidipine does not increase pulse rates (PRs) and is associated with reduced occurrence of pedal edema. Cilnidipine is an effective treatment choice for individuals with mild to moderate essential HTN, whether it is administered alone or in conjunction with other treatment modalities.